Nanomedicine Market Report

Nanomedicine Market Analysis By Products (Therapeutics, Regenerative Medicine, Diagnostics), By Application (Clinical Oncology, Infectious diseases), By Nanomolecule (Gold, Silver, Iron Oxide, Alumina), & Segment Forecasts, 2020 - 2025

  • Report ID: 978-1-68038-942-5
  • Number of Pages: 165
  • Format: Electronic (PDF)
  • Historical Range: 2013 - 2018
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology
                1.1 Information procurement
                1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Nanomedicine Market Variables, Trends & Scope
                3.1 Market Segmentation & Scope
                    3.1.1 Market driver analysis
                        3.1.1.1 Rising level of government participation in R&D funding
                        3.1.1.2 Introduction of technological advancements in diagnostic procedures
                        3.1.1.3 Rising usage of nanomedicine in drug delivery technology
                    3.1.2 Market restraint analysis
                        3.1.2.1 Side effects associated with intake of nanoparticles and lower adoption rate by patients
                        3.1.2.2 Hesitant uptake by medical and pharmaceutical industry
                3.2 Penetration & Growth Prospect Mapping For Products, 2016 & 2025
                3.3 Nanomedicine - SWOT Analysis, By Factor (political & legal, economic and technological)
                3.4 Industry Analysis - Porter’s
Chapter 4 Nanomedicine Market: Product Estimates & Trend Analysis
                4.1 Nanomedicine market: product movement analysis
                4.2 Therapeutics
                    4.2.1 Global therapeutics market, 2013 - 2025 (USD Billion)
                4.3 Regenerative medicine
                    4.3.1 Global regenerative medicine market, 2013 - 2025 (USD Billion)
                4.4 In-vitro diagnostics
                    4.4.1 Global in-vitro diagnostics market, 2013 - 2025 (USD Billion)
                4.5 In-vivo diagnostics
                    4.5.1 Global in-vivo diagnostics market, 2013 - 2025 (USD Billion)
                4.6 Vaccines
                    4.6.1 Global vaccines market, 2013 - 2025 (USD Billion)
Chapter 5 Nanomedicine Market: Application Estimates & Trend Analysis
                5.1 Nanomedicine market: Application movement analysis
                5.2 Clinical oncology
                    5.2.1 Global clinical oncology market, 2013 - 2025 (USD Billion)
                5.3 Infectious diseases
                    5.3.1 Global infectious diseases market, 2013 - 2025 (USD Billion)
                5.4 Clinical cardiology
                    5.4.1 Global clinical cardiology market, 2013 - 2025 (USD Billion)
                5.5 Orthopedics
                    5.5.1 Global orthopedics market, 2013 - 2025 (USD Billion)
                5.6 Others
                    5.6.1 Global other applications market, 2013 - 2025 (USD Billion)
Chapter 6 Nanomedicine Market: Nanomolecule Type Estimates & Trend Analysis
                6.1 Nanomedicine Market: Nanomolecule Type Movement Analysis
                6.2 Nanomolecules
                    6.2.1 Global nanomolecules market, 2013 - 2025 (USD Billion)
                    6.2.2 Nanoparticles & quantum dots
                        6.2.2.1 Global nanoparticles & quantum dots market, 2013 - 2025 (USD Billion)
                        6.2.2.2 Metal & metal compounds
                            6.2.2.2.1 Global metal & metal compounds nanoparticles market, by type nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.2 Gold nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.3 Silver nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.4 Alumina nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.5 Iron oxide nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.6 Gadolinium nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.7 Other metal & metal oxide nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                        6.2.2.3 Global metal & metal compound nanoparticles market, by application
                            6.2.2.3.1 In-vivo Imaging
                            6.2.2.3.2 Targeted drug delivery
                            6.2.2.3.3 Proton therapy
                            6.2.2.3.4 In-vitro assays
                            6.2.2.3.5 Cell & phantom imaging
                        6.2.2.4 Liposomes
                            6.2.2.4.1 Global liposomes market, 2013 - 2025 (USD Billion)
                        6.2.2.5 Polymer & polymer drug conjugates
                            6.2.2.5.1 Global polymer & polymer drug conjugates market, 2013 - 2025 (USD Billion)
                        6.2.2.6 Hydrogel nanoparticles
                            6.2.2.6.1 Global hydrogel nanoparticles market, 2013 - 2025 (USD Billion)
                        6.2.2.7 Dendrimers
                            6.2.2.7.1 Global dendrimers market, 2013 - 2025 (USD Billion)
                        6.2.2.8 Inorganic nanoparticles
                            6.2.2.8.1 Global inorganic nanoparticles market, 2013 - 2025 (USD Billion)
                    6.2.3 Nanoshells
                        6.2.3.1 Global nanoshells market, 2013 - 2025 (USD Billion)
                    6.2.4 Nanotubes
                        6.2.4.1 Global nanotubes market, 2013 - 2025 (USD Billion)
                    6.2.5 Nanodevices
                        6.2.5.1 Global nanodevices market, 2013 - 2025 (USD Billion)
Chapter 7 Nanomedicine Market: Regional Estimates & Trend Analysis, by Product, Application, & Nanomolecule Type
                7.1 Nanomedicine market share by region, 2016 & 2025
                7.2 North America
                    7.2.1 North America nanomedicine market, 2013 - 2025 (USD Billion)
                    7.2.2 The U.S.
                        7.2.2.1 U.S. nanomedicine market, 2013 - 2025 (USD Billion)
                    7.2.3 Canada
                        7.2.3.1 Canada nanomedicine market, 2013 - 2025 (USD Billion)
                7.3 Europe
                    7.3.1 Europe nanomedicine market, 2013 - 2025 (USD Billion)
                    7.3.2 Germany
                        7.3.2.1 Germany nanomedicine market, 2013 - 2025 (USD Billion)
                    7.3.3 The U.K.
                        7.3.3.1 U.K. nanomedicine market, 2013 - 2025 (USD Billion)
                7.4 Asia Pacific.
                    7.4.1 Asia Pacific nanomedicine market, 2013 - 2025 (USD Billion)
                    7.4.2 Japan
                        7.4.2.1 Japan nanomedicine market, 2013 - 2025 (USD Billion)
                    7.4.3 China
                        7.4.3.1 China nanomedicine market, 2013 - 2025 (USD Billion)
                7.5 Latin America
                    7.5.1 Latin America nanomedicine market, 2013 - 2025 (USD Billion)
                    7.5.2 Brazil
                        7.5.2.1 Brazil nanomedicine market, 2013 - 2025 (USD Billion)
                7.6 Middle East & Africa
                    7.6.1 Middle East & Africa nanomedicine market, 2013 - 2025 (USD Billion)
                    7.6.2 South Africa
                        7.6.2.1 South Africa nanomedicine market, 2013 - 2025 (USD Billion)
Chapter 8 Competitive Landscape
                8.1 Strategy framework
                8.2 Market participation categorization
                8.3 Company Profiles
                    8.3.1 Arrowhead Pharmaceuticals, Inc.
                        8.3.1.1 Company overview
                        8.3.1.2 CALANDO PHARMACEUTICALS, Inc.
                        8.3.1.3 Financial performance
                        8.3.1.4 Product benchmarking
                    8.3.2 Brigham and Women's Hospital (BWH)
                        8.3.2.1 Company overview
                        8.3.2.2 Financial performance
                        8.3.2.3 Product benchmarking
                    8.3.3 Nanospectra Biosciences, Inc.
                        8.3.3.1 Company overview
                        8.3.3.2 Financial performance
                        8.3.3.3 Product benchmarking
                    8.3.4 ABLYNX
                        8.3.4.1 Company overview
                        8.3.4.2 Financial performance
                        8.3.4.3 Product benchmarking
                        8.3.4.4 Strategic initiatives
                    8.3.5 AMAG Pharmaceuticals
                        8.3.5.1 Company overview
                        8.3.5.2 Financial performance
                        8.3.5.3 Product benchmarking
                        8.3.5.4 Strategic initiatives
                    8.3.6 Bio-Gate AG
                        8.3.6.1 Company overview
                        8.3.6.2 Financial performance
                        8.3.6.3 Product benchmarking
                        8.3.6.4 Strategic initiatives
                    8.3.7 Celgene Corporation
                        8.3.7.1 Company overview
                        8.3.7.2 Abraxis BioScience, Inc.
                        8.3.7.3 Financial Performance
                        8.3.7.4 Product benchmarking
                        8.3.7.5 Strategic initiatives
                    8.3.8 Johnson & Johnson Services, Inc.
                        8.3.8.1 Company overview
                        8.3.8.2 Financial performance
                        8.3.8.3 Product benchmarking
                        8.3.8.4 Strategic initiatives
                    8.3.9 Pfizer, Inc.
                        8.3.9.1 Company overview
                        8.3.9.2 Financial performance
                        8.3.9.3 Product benchmarking
                        8.3.9.4 Strategic initiatives
                    8.3.10 Abbott
                        8.3.10.1 Company overview
                        8.3.10.2 Financial performance
                        8.3.10.3 Product benchmarking
                        8.3.10.4 Strategic initiatives
                    8.3.11 Leadiant Biosciences, Inc.
                        8.3.11.1 Company overview
                        8.3.11.2 Financial performance
                        8.3.11.3 Product benchmarking
                        8.3.11.4 Strategic initiatives
                    8.3.12 Teva Pharmaceutical Industries Ltd.
                        8.3.12.1 Company overview
                        8.3.12.2 Financial performance
                        8.3.12.3 Product benchmarking
                    8.3.13 CYTIMMUNE SCIENCES, INC.
                        8.3.13.1 Company overview
                        8.3.13.2 Financial performance
                        8.3.13.3 Product benchmarking
                        8.3.13.4 Strategic initiatives
                    8.3.14 Merck & Co Ltd
                        8.3.14.1 Company Overview
                        8.3.14.2 Financial performance
                        8.3.14.3 Product benchmarking
                        8.3.14.4 Strategic initiatives
                    8.3.15 Gilead
                        8.3.15.1 Company Overview
                        8.3.15.2 Financial performance
                        8.3.15.3 Product benchmarking
                    8.3.16 Epeius Biotechnologies Corporation
                        8.3.16.1 Company overview
                        8.3.16.2 Financial performance
                        8.3.16.3 Product benchmarking


List of Tables

TABLE 1 Nanofibers in Regenerative Medicine
TABLE 2 North America nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 3 North America nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 4 North America nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 5 North America nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 6 North America nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 7 North America nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 8 North America nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 9 North America nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 10 North America metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 11 North America metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 12 North America metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 13 North America metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 14 Patent applicant for nanotechnology based therapeutics
TABLE 15 U.S. nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 16 U.S. nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 17 U.S. nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 18 U.S. nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 19 U.S. nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 20 U.S. nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 21 U.S. nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 22 U.S. nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 23 U.S. metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 24 U.S. metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 25 U.S. metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 26 U.S. metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 27 Nanotechnology organizations which are involved in publishing nanoscience based articles
TABLE 28 Canada nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 29 Canada nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 30 Canada nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 31 Canada nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 32 Canada nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 33 Canada nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 34 Canada nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 35 Canada nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 36 Canada metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 37 Canada metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 38 Canada metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 39 Canada metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 40 Europe nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 41 Europe nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 42 Europe nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 43 Europe nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 44 Europe nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 45 Europe nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 46 Europe nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 47 Europe nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 48 Europe metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 49 Europe metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 50 Europe metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 51 Europe metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 52 Germany nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 53 Germany nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 54 Germany nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 55 Germany nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 56 Germany nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 57 Germany nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 58 Germany nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 59 Germany nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 60 Germany metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 61 Germany metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 62 Germany metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 63 Germany metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 64 U.K. nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 65 U.K. nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 66 U.K. nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 67 U.K. nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 68 U.K. nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 69 U.K. nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 70 U.K. nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 71 U.K. nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 72 U.K. metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 73 U.K. metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 74 U.K. metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 75 U.K. metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 76 Asia Pacific nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 77 Asia Pacific nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 78 Asia Pacific nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 79 Asia Pacific nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 80 Asia Pacific nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 81 Asia Pacific nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 82 Asia Pacific nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 83 Asia Pacific nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 84 Asia Pacific metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 85 Asia Pacific metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 86 Asia Pacific metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 87 Asia Pacific metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 88 Japan nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 89 Japan nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 90 Japan nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 91 Japan nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 92 Japan nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 93 Japan nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 94 Japan nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 95 Japan nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 96 Japan metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 97 Japan metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 98 Japan metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 99 Japan metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 100 China nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 101 China nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 102 China nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 103 China nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 104 China nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 105 China nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 106 China nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 107 China nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 108 China metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 109 China metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 110 China metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 111 China metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 112 Latin America nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 113 Latin America nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 114 Latin America nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 115 Latin America nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 116 Latin America nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 117 Latin America nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 118 Latin America nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 119 Latin America nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 120 Latin America metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 121 Latin America metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 122 Latin America metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 123 Latin America metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 124 Brazil nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 125 Brazil nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 126 Brazil nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 127 Brazil nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 128 Brazil nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 129 Brazil nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 130 Brazil nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 131 Brazil nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 132 Brazil metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 133 Brazil metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 134 Brazil metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 135 Brazil metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 136 MEA nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 137 MEA nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 138 MEA nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 139 MEA nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 140 MEA nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 141 MEA nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 142 MEA nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 143 MEA nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 144 MEA metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 145 MEA metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 146 MEA metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 147 MEA metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 148 South Africa nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 149 South Africa nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 150 South Africa nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 151 South Africa nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 152 South Africa nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 153 South Africa nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 154 South Africa nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 155 South Africa nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 156 South Africa metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 157 South Africa metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 158 South Africa metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 159 South Africa metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for products, 2016 & 2025
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Nanomedicine market product outlook key takeaways
FIG. 16 Nanomedicine market: Product movement analysis
FIG. 17 Global therapeutics market, 2013 - 2025 (USD Billion)
FIG. 18 Global regenerative medicine market, 2013 - 2025 (USD Billion)
FIG. 19 Global in-vitro diagnostics market, 2013 - 2025 (USD Billion)
FIG. 20 Global in-vivo diagnostics market, 2013 - 2025 (USD Billion)
FIG. 21 Global vaccines market, 2013 - 2025 (USD Billion)
FIG. 22 Nanomedicine market: Application outlook key takeaways
FIG. 23 Global nanomedicine market: Application movement analysis
FIG. 24 Cancer cases per year
FIG. 25 Global clinical oncology market, 2013 - 2025 (USD Billion)
FIG. 26 Global infectious diseases market, 2013 - 2025 (USD Billion)
FIG. 27 Global clinical cardiology market, 2013 - 2025 (USD Billion)
FIG. 28 Global orthopedics market, 2013 - 2025 (USD Billion)
FIG. 29 Global other applications market, 2013 - 2025 (USD Billion)
FIG. 30 Nanomedicine market: Nanomolecule type outlook key takeaways
FIG. 31 Global nanomedicine market: Nanomolecule type movement analysis
FIG. 32 Global nanomolecules market, 2013 - 2025 (USD Billion)
FIG. 33 Global nanoparticles & quantum dots market, 2013 - 2025 (USD Billion)
FIG. 34 Global metal & metal compounds nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 35 Global gold nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 36 Global silver nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 37 Global alumina nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 38 Global iron oxide nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 39 Global gadolinium nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 40 Global other metal & metal oxide nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 41 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
FIG. 42 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
FIG. 43 Global proton therapy market, 2013 - 2025 (USD Billion)
FIG. 44 Global in-vitro assays market, 2013 - 2025 (USD Billion)
FIG. 45 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)
FIG. 46 Global liposomes market, 2013 - 2025 (USD Billion)
FIG. 47 Global polymer & polymer drug conjugates market, 2013 - 2025 (USD Billion)
FIG. 48 Global hydrogel nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 49 Global dendrimers market, 2013 - 2025 (USD Billion)
FIG. 50 Global inorganic nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 51 Global nanoshells market, 2013 - 2025 (USD Billion)
FIG. 52 Global nanotubes market, 2013 - 2025 (USD Billion)
FIG. 53 Global nanodevices market, 2013 - 2025 (USD Billion)
FIG. 54 Regional market place: Key take away
FIG. 55 Nanomedicine regional outlook, 2016 & 2025
FIG. 56 North America nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 57 U.S. nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 58 Canada. nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 59 Europe nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 60 Germany nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 61 U.K. nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 62 Asia Pacific nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 63 Japan nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 64 China nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 65 Latin America nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 66 Brazil nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 67 Middle East & Africa nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 68 South Africa nanomedicine market, 2013 - 2025 (USD Billion)
FIG. 69 Strategy framework
FIG. 70 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.